Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.440
+0.160 (7.02%)
At close: Aug 7, 2026, 4:00 PM EDT
2.437
-0.003 (-0.13%)
After-hours: Aug 7, 2026, 7:35 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $176.24 million as of August 7, 2026. Its market cap has increased by 107.82% in one year.
Market Cap
176.24M
Enterprise Value
79.00M
1-Year Change
107.82%
Ranking
Category
Stock Price
$2.44
ChartMarket Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $176.24M, a decrease of -71.50%. That is a compound annual growth rate of -21.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 176.24M | 37.89% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 170.28M |
| OnKure Therapeutics | 168.05M |
| Innate Pharma | 166.35M |
| Korro Bio | 166.28M |
| Alector | 165.43M |
| LENZ Therapeutics | 165.24M |
| Aardvark Therapeutics | 164.06M |
| Caribou Biosciences | 159.68M |